Stock Earnings

Question 1

How did PTGX's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Protagonist Therapeutics Inc is $-0.62, not beating expectations of $-0.65.

Question 2

How did Protagonist Therapeutics Inc PTGX's revenue perform in the last quarter?

Accepted Answer

Protagonist Therapeutics Inc revenue for the last quarter is $-0.62

Question 3

What is the revenue estimate for Protagonist Therapeutics Inc?

Accepted Answer

According to 13 of Wall street analyst, the revenue estimate of Protagonist Therapeutics Inc range from $236.25M to $0.0

Question 4

What's the earning quality score for Protagonist Therapeutics Inc?

Accepted Answer

Protagonist Therapeutics Inc has a earning quality score of B+/53.04428. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Protagonist Therapeutics Inc report earnings?

Accepted Answer

Protagonist Therapeutics Inc next earnings report is expected in 2026-02-04

Question 6

What are Protagonist Therapeutics Inc's expected earnings?

Accepted Answer

Protagonist Therapeutics Inc expected earnings is $3.7M, according to wall-street analysts.

Question 7

Did Protagonist Therapeutics Inc beat earnings expectations?

Accepted Answer

Protagonist Therapeutics Inc recent earnings of $4.71M beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-0.65	$-0.62	-4.61%	MISSED
Q2 '25	$-0.59	$-0.55	-6.77%	MISSED
Q1 '25	$-0.23	$-0.19	-17.39%	MISSED
Q4 '24	$0.32	$1.98	+518.75%	BEAT
Q3 '24	$-0.61	$-0.54	-11.47%	MISSED

Protagonist Therapeutics Inc (PTGX) Price

PTGX Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ